Union Minister Dr. Jitendra Singh Launches UMMID Programme for Rare Genetic Disorders

<h3>Overview</h3> <p>Union Minister of State <strong>Dr. Jitendra Singh</strong> dedicated the <span class='key-term' data-definition='Unique Methods of Management of Inherited Disorders — a national programme to screen, diagnose and manage rare genetic diseases, aligning with GS3: Health and Social Welfare'>UMMID</span> programme to the nation. The initiative aims to build a coordinated mechanism for early detection, affordable diagnosis and management of <span class='key-term' data-definition='Rare Genetic Disorders — inherited conditions affecting a small portion of the population but causing high health burden, covered under GS3: Health and GS4: Ethics'>Rare Genetic Disorders</span> across India.</p> <h3>Key Developments</h3> <ul> <li>Launch of the <span class='key-term' data-definition='Unique Methods of Management of Inherited Disorders — a national programme to screen, diagnose and manage rare genetic diseases, aligning with GS3: Health and Social Welfare'>UMMID</span> Dashboard for real‑time monitoring of diagnostics and counselling.</li> <li>Release of the <strong>UMMID Compendium</strong> documenting protocols, best practices and institutional partnerships.</li> <li>Establishment of nearly <strong>30 NIDAN Kendras</strong> to provide advanced <span class='key-term' data-definition='Genetic Diagnostics — tests that identify DNA variations causing disease, relevant for GS3: Health and Science'>genetic diagnostics</span> and counselling in non‑metropolitan areas.</li> <li>Screening of close to <strong>three lakh individuals</strong> since the programme’s inception, with outreach extended to Aspirational Districts.</li> <li>Integration of <span class='key-term' data-definition='Precision Medicine — medical approach that tailors treatment to an individual’s genetic makeup, important for GS3: Health and Science'>Precision Medicine</span> concepts into the public health model, preparing the system for genome‑based therapies.</li> </ul> <h3>Important Facts</h3> <p>The programme is coordinated by the <span class='key-term' data-definition='Department of Biotechnology (DBT) — a Ministry of Science & Technology body that funds and coordinates biotechnology research, pertinent to GS3: Science & Technology'>Department of Biotechnology</span> and involves senior scientists, clinicians and state health agencies. It combines prenatal screening, newborn testing, genetic counselling, clinician training and community outreach under a single framework.</p> <p>India’s vast genetic diversity makes the task complex but also offers a unique research base for developing tailored therapies.</p> <h3>UPSC Relevance</h3> <p>Understanding <span class='key-term' data-definition='Precision Medicine — medical approach that tailors treatment to an individual’s genetic makeup, important for GS3: Health and Science'>Precision Medicine</span> is essential for GS3 questions on health technology and for GS4 ethics discussions on equitable access. The role of the <span class='key-term' data-definition='Department of Biotechnology (DBT) — a Ministry of Science & Technology body that funds and coordinates biotechnology research, pertinent to GS3: Science & Technology'>Department of Biotechnology</span> illustrates inter‑ministerial coordination, a key theme in GS2 Polity. The programme’s focus on affordable, accessible care aligns with the government’s broader health reforms under Prime Minister Narendra Modi.</p> <h3>Way Forward</h3> <ul> <li>Scale up the network of <span class='key-term' data-definition='NIDAN Kendras — National Institutes for Diagnosis and Advanced Nutrition, centres set up for advanced genetic testing and counselling, linked to GS3: Health infrastructure'>NIDAN Kendras</span> to cover all remote districts.</li> <li>Strengthen capacity‑building for clinicians in <span class='key-term' data-definition='Genetic Diagnostics — tests that identify DNA variations causing disease, relevant for GS3: Health and Science'>genetic diagnostics</span> and counselling.</li> <li>Leverage data from the <strong>UMMID Dashboard</strong> to inform policy on rare disease funding and insurance coverage.</li> <li>Promote research on genome‑based therapies to transition from screening to curative interventions.</li> </ul>